Status:
RECRUITING
Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Anaphylaxis
Eligibility:
All Genders
Brief Summary
The Anaphylaxis Registry aims to assess data in a standardized form about symptoms, triggers, cofactors and therapy management from patients who experienced an anaphylactic reaction. This should impro...
Detailed Description
A better understanding of the triggers and pathology of anaphylactic reactions could lead to a better diagnosis and prophylaxis to avoid the occurence of these life-threatening allergic reactions. Thi...
Eligibility Criteria
Inclusion
- Anaphylactic reaction within the past 12 months
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT05210543
Start Date
January 1 2007
End Date
December 1 2030
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin
Berlin, Germany, 10117